EyePoint announced conference appearances, a planned presentation of LUCIA Phase 3 data, and a date for its third-quarter report. These are upcoming events, not new trial or financial results, so they do not change the company’s outlook.
These dates give investors chances to hear from EyePoint and see trial data. The announcement includes no trial findings or third-quarter figures, so it adds no new evidence about the company’s results.
Follow EyePoint Pharmaceuticals, Inc. (EYPT) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for EYPT